While a vast majority of heart transplants (HT) in the United States are successful, unplanned hospitalizations are still incredibly common. In fact, one 2018 analysis found that 62% of heart transplant patients are hospitalized within 60 days of the procedure.
What leads to these unplanned hospitalizations? A team of specialists aimed to find out, sharing its findings in Current Problems in Cardiology.[1]
Read more in Cardiovascular Business.
“She has so much more energy and is eating so much more. She is also moving and walking more than she ever did.”
Four-year-old Stella Allison has always loved telling jokes and playing dress up.
With energy that is contagious and a smile that lights up a room, her mom Kyley Barthlow says Stella has grown into a high-spirited and chatty child – but was born a real fighter.
Read the full story from Seattle Children’s.
Key points:
-OPTN Board to take up recommendation June 27
-If approved, implementation may occur within 30 days
-Transplant programs and labs should be aware of the pending action and consider options for transition
At its next in-person meeting, the Board of Directors of the Organ Procurement and Transplantation Network (OPTN) will consider a proposal to require transplant hospitals to use race-neutral calculations when estimating a patient’s glomerular filtration rates (GFR). This proposed change aims to reduce health disparities and address inequities for Black kidney candidates by more accurately estimating their GFR values. The board will next meet in Richmond, Va., June 26-27, 2022. Read more from UNOS.
Newswise — BALTIMORE, June 22, 2022 – Six months ago, University of Maryland School of Medicine surgeon-scientists successfully implanted a genetically modified pig heart into a 57 year-old patient with terminal heart disease in a first-of-its-kind surgery. It was considered an early success because the patient lived for two months with a strong functioning heart showing no obvious signs of rejection, according to a new paper published today in the New England Journal of Medicine. Read more in News Wise.
Maria Contreras and Monica Davis share many things — including a vital organ.
The two Ohio women, who refer to themselves as “split-liver sisters,” received a liver transplant on July 1, 2020. But it wasn’t an ordinary transplant surgery: They had a split-liver transplantation, in which a donor’s liver was divided into two distinct portions, which were then implanted into each patient. Read the full story in The Washington Post.
Summer is just around the corner. The upcoming warmer months evoke images of outdoor activities and fun, and for the transplant community—the return of the Transplant Games.
More than 8,000 transplant recipients are expected to compete at the 2022 Transplant Games taking place in San Diego, California from July 29 – August 3. The six-day competition, hosted by Transplant Life Foundation, is expected to be the largest to date since the event’s inception in 1990. Read more on CareDx.com.
Recently reported study findings provide a detailed look at how a major adverse cardiovascular event (MACE) after kidney transplantation adversely affects survival and identify which patients are at elevated risk for MACE. Data also demonstrate that patients who receive a kidney transplant are at lower MACE risk compared with those who remain on dialysis.
In a study of 30,325 KTRs in England published in Kidney International, a MACE occurred in 781 within the first year of transplantation surgery. Read more in Renal & Urology News.
Interested in the latest transplant news, events, and information? Join our community. Sign up for the “Our Transplant Journeys” e-newsletter, distributed once a month. To get on the list, sign-up here.
You just found out you need an organ transplant. Whether it’s a heart, kidney, liver or lung, there are some key fundamentals to keep in mind as you navigate your transplant journey. Who better to share advice than those who have been through it?
Below are words of advice transplant recipients shared on Facebook and Instagram from their experiences during their transplant journeys. Read the full story on CareDx.com here.
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Jun. 21, 2022– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the release of its first environmental, social and governance (ESG) report.
“At CareDx, our mission and 100% dedication to improving the transplant ecosystem with innovative and intelligent solutions to improve patient outcomes shapes every aspect of our business and seamlessly integrates with an ESG framework,” said Reg Seeto, CareDx CEO and President. “As a leader in transplantation, we have a great responsibility to the transplant community, and using this framework is a natural step in our company’s evolution as we search for ways to continue to exemplify our values through actions which have a meaningful impact on our community, patients, and other stakeholder groups.” Read the full press release on CareDx.com here.